Skip to main content
. 2019 Jan 22;10:8. doi: 10.3389/fimmu.2019.00008

Figure 1.

Figure 1

The multiple obstacles to effective anti-tumor immune responses following successful priming of tumor antigen-specific T-cells by a vaccine. Each obstacle offers opportunities for therapeutic intervention in order to increase vaccine efficacy, as discussed in more detail in the main text.

HHS Vulnerability Disclosure